MAIA BIOTECHNOLOGY INC's ticker is and the CUSIP is 552641102. A total of 22 filers reported holding MAIA BIOTECHNOLOGY INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $268,542 | +618.4% | 78,521 | +362.1% | 0.00% | – |
| Q1 2024 | $37,383 | +85.7% | 16,992 | -1.3% | 0.00% | – |
| Q4 2023 | $20,135 | -34.5% | 17,209 | +23.2% | 0.00% | – |
| Q3 2023 | $30,739 | +74.3% | 13,972 | +74.3% | 0.00% | – |
| Q2 2023 | $17,638 | +27.3% | 8,017 | +100.1% | 0.00% | – |
| Q1 2023 | $13,860 | +1.9% | 4,006 | +3.4% | 0.00% | – |
| Q4 2022 | $13,598 | +13.3% | 3,874 | +8.5% | 0.00% | – |
| Q3 2022 | $12,000 | – | 3,572 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SABBY MANAGEMENT, LLC | 130,510 | $152,697 | 0.15% |
| Centric Wealth Management | 67,198 | $96,765 | 0.03% |
| XTX Topco Ltd | 23,965 | $28,039 | 0.01% |
| Naviter Wealth, LLC | 22,168 | $25,937 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 75,700 | $88,569 | 0.00% |
| Brookstone Capital Management | 12,658 | $14,810 | 0.00% |
| NORTHERN TRUST CORP | 20,273 | $23,719 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 998 | $1,168 | 0.00% |
| Sunbelt Securities, Inc. | 150 | $176 | 0.00% |